Generated by GPT-5-mini| The Dropout | |
|---|---|
| Show name | The Dropout |
| Genre | Drama, Biographical |
| Based on | "The Dropout" podcast |
| Developer | Elizabeth Meriwether |
| Starring | Amanda Seyfried |
| Country | United States |
| Language | English |
| Camera | Single-camera |
| Network | Hulu |
| Release date | 2022 |
The Dropout is a biographical drama miniseries chronicling the rise and fall of Elizabeth Holmes and the biotechnology startup Theranos. The series dramatizes corporate ambition, scientific claims, and courtroom consequences through the lens of a high-profile Silicon Valley saga, portraying interactions with investors, board members, and media figures. It adapts narratives from investigative journalism and a popular podcast into a serialized television format.
The series presents a dramatized account centered on Elizabeth Holmes, juxtaposing scenes involving Theranos, Stanford University, Walgreens, Safeway, Ramesh "Sunny" Balwani, Henry Kissinger, George Shultz, Rupert Murdoch, Tim Draper, Larry Ellison, Jamie Dimon, Sheila Kaplan, John Carreyrou, The Wall Street Journal, Fortune (magazine), and Bloomberg L.P. The narrative interweaves depictions of startup culture with portrayals of investors such as Betsy DeVos, William "Bill" Frist, Richard Kovacevich, Don Lucas, Larry Summers, and David Boies. Episodes reference conducting business with pharmacy chains, interacting with venture capitalists from firms like Sequoia Capital, Founders Fund, Kleiner Perkins, and NEA (New Enterprise Associates), and courting media platforms such as CNBC, 60 Minutes (Australian TV series), 60 Minutes (American TV program), and CBS News. The dramatization includes legal and regulatory bodies like U.S. Securities and Exchange Commission, Food and Drug Administration, Centers for Medicare & Medicaid Services, and courtroom scenes echoing trials in federal venues.
Development drew from investigative reporting by John Carreyrou and the podcast hosted by Rebecca Jarvis and produced by ABC News. Producers consulted material involving Elizabeth Holmes (businesswoman), her tenure at Theranos, and earlier links to Stanford research. Creative teams negotiated rights with journalists from The Wall Street Journal, contributors from Rolling Stone (India), and producers affiliated with ABC Audio, Rumble, and independent production companies. The series development intersected with executives and showrunners connected to 20th Television, Hulu, Disney, and independent financiers including individuals associated with Laurene Powell Jobs and Emerson Collective. Showrunners and writers referenced business histories involving Arthur Andersen, Enron, Theranos board members, and high-profile entrepreneurs such as Mark Zuckerberg, Elon Musk, Steve Jobs, Bill Gates, Jeff Bezos, Peter Thiel, Reid Hoffman, Marc Andreessen, and Paul Allen to situate the Silicon Valley milieu.
Principal photography occurred in locations doubling for Palo Alto, San Francisco, Los Angeles, and corporate offices styled after Stanford Research Park and startup incubators reminiscent of Y Combinator spaces. Directors and producers who previously worked on series for HBO, Netflix, Amazon Prime Video, and Showtime guided episodes. The series premiered on Hulu with distribution deals explored for international outlets such as Disney+, Star (Disney+), BBC Studios, Channel 4, and streaming platforms in partnerships with distributors like Sony Pictures Television and Lionsgate. Promotional appearances included cast interviews on The Tonight Show Starring Jimmy Fallon, Late Night with Seth Meyers, The View, and festival circuits including Sundance Film Festival and Toronto International Film Festival satellite events.
Lead casting features Amanda Seyfried portraying Elizabeth Holmes opposite actors portraying Theranos associates and public figures: casts depict Ramesh "Sunny" Balwani, George Shultz, Henry Kissinger, William "Bill" Frist, James Mattis-style military references, and venture capitalists reminiscent of figures from Sequoia Capital, Founders Fund, and NEA. Supporting roles evoke interactions with journalists from The Wall Street Journal, Bloomberg, Vanity Fair, Fortune (magazine), and legal counsel resembling partners from firms like Boies Schiller Flexner LLP and Cravath, Swaine & Moore. Guest appearances include characters modeled on executives from Walgreens Boots Alliance, Safeway, UnitedHealth Group, and biopharma executives echoing leaders from Amgen, Genentech, Roche, Quest Diagnostics, and LabCorp. The ensemble reflects a cross-section of Silicon Valley entrepreneurs, investors, board members, and regulators drawn from institutions like Stanford University School of Medicine, Harvard Business School, and MIT.
Critics compared the dramatization to other corporate exposés and true-crime adaptations involving The Social Network, Icarus (film), Dirty Money (TV series), and The Inventor: Out for Blood in Silicon Valley. Reviews in outlets such as The New York Times, The Washington Post, Los Angeles Times, Variety (magazine), The Hollywood Reporter, Vogue (magazine), and The Atlantic evaluated performances, narrative framing, and factual accuracy. The series generated renewed attention to reporting by John Carreyrou and prompted scholarly commentary from academics at Harvard Law School, Stanford Graduate School of Business, Columbia University, Yale Law School, University of California, Berkeley, and policy analysts connected to Brookings Institution, Hoover Institution, and RAND Corporation. Cultural conversations referenced comparisons to other industry scandals involving Enron, Theranos, Google (company), Facebook, Uber, and WeWork, influencing debates in media ethics and regulatory reform advocated by lawmakers in United States Congress and committees such as the Senate Committee on Health, Education, Labor, and Pensions.
The production and release provoked responses from lawyers and principals associated with Theranos, involving defamation concerns, rights to portrayal, and settlement negotiations with figures who engaged counsel from firms like Boies Schiller Flexner LLP, Gibson, Dunn & Crutcher, and Latham & Watkins. Lawsuits and pretrial motions in federal courts cited testimonies and filings from regulatory actions by the Securities and Exchange Commission and enforcement by Centers for Medicare & Medicaid Services. Media organizations including The Wall Street Journal and Bloomberg L.P. contested elements of dramatization against journalistic records. Post-release discourse involved documentaries and podcasts revisiting the story, with contributions from producers linked to Wondery, Gimlet Media, Panoply Media, and independent journalists who previously reported on Theranos.
Category:Television miniseries